Clinical Trial Update: Safety and Efficacy of Changing to DuoTrav From Prior Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of switching to DuoTrav from prior therapy in glaucoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED